Activation of the NF-κB signalling pathway in diffuse large B-cell lymphoma: Clinical implications

Histopathology

Volumn 53, Issue 4, 2008, Pages 441-449

  Espinosa, I ^b   Briones, J ^a,b   Bordes, R ^b   Brunet, S ^b   Martino, R ^b   Sureda, A ^b   Sierra, J ^b   Prat, J ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Diffuse large B cell lymphoma; Immunohistochemistry; NF B; Prognosis

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PREDNISONE; PROTEIN BCL 2; VINCRISTINE; CARRIER PROTEIN; HSAJ2425 PROTEIN, HUMAN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; COMBINATION CHEMOTHERAPY; FEMALE; GERMINAL CENTER; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TREATMENT OUTCOME; TUMOR CELL; CLASSIFICATION; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 52649091710     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03139.x     Document Type: Article

References (29)

1. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002 2 725 734.
2. Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 2005 5 435 445.
3. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000 18 621 663.
4. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005 5 749 759.
5. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 1999 274 30353 30356.
6. Sasaki CY, Barberi TJ, Ghosh P, Longo DL. Phosphorylation of RelA/p65 on serine 536 defines an I[kappa]B[alpha]-independent NF-[kappa]B pathway. J. Biol. Chem. 2005 280 34538 34547.
7. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 2001 194 1861 1874.
8. Jaffe ES, Harris NL, Stein H, Vardiman JW. Diffuse large B-cell lymphoma. Lyon: IARC Press, 2001 171 174.
9. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004 103 275 282.
10. Kaplan GL, Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958 53 457 481.
11. Peto R, Pike MC. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics 1973 29 579 584.
12. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J. Clin. Oncol. 1999 17 1244.
13. Nakanishi C, Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 2005 5 297 309.
14. Staudt LM, Singh H, Sen R, Wirth T, Sharp PA, Baltimore D. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 1986 323 640 643.
15. Houldsworth J, Olshen AB, Cattoretti G et al. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood 2004 103 1862 1868.
16. Feuerhake F, Kutok JL, Monti S et al. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005 106 1392 1399.
17. Birbach A, Gold P, Binder BR, Hofer E, de Martin R, Schmid JA. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem. 2002 277 10842 10851.
18. Rodriguez A, Martinez N, Camacho FI et al. Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement. Clin. Cancer Res. 2004 10 6796 6806.
19. Manara GC, Scandroglio R, De Panfilis G, Ferrari C. Cell subpopulations in the paracortical area of the normal human lymphnode defined by monoclonal antibodies. Basic Appl. Histochem. 1983 27 267 276.
20. Basso K, Klein U, Niu H et al. Tracking CD40 signaling during germinal center development. Blood 2004 104 4088 4096.
21. Colomo L, Lopez-Guillermo A, Perales M et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003 101 78 84.
22. De Paepe P, Achten R, Verhoef G et al. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas. J. Clin. Oncol. 2005 23 7060 7068.
23. Huang JZ, Sanger WG, Greiner TC et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 2002 99 2285 2290.
24. Martinez-Delgado B, Cuadros M, Honrado E et al. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia 2005 19 2254 2263.
25. Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 2005 115 2625 2632.
26. Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol. Cell 2004 13 853 865.
27. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC. p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 2004 279 26115 26125.
28. Miyamoto S. RelA life and death decisions. Mol. Cell 2004 13 763 764.
29. Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 2004 5 392 401.